A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity

EMBO Journal

Volumn 16, Issue 24, 1997, Pages 7279-7286

  Fazioli, Francesca ^a,b   Resnati, Massimo ^a,b   Sidenius, Nicolai ^a,b   Higashimoto, Yuichiro ^c   Appella, Ettore ^c   Blasi, Francesco ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GUANINE NUCLEOTIDE BINDING PROTEIN; MUTANT PROTEIN; PERTUSSIS TOXIN; PROTEIN TYROSINE KINASE; SYNTHETIC PEPTIDE; UROKINASE; UROKINASE RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; CHEMOKINES; CHEMOTAXIS; DNA PRIMERS; GTP-BINDING PROTEINS; HUMANS; INFLAMMATION; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PEPTIDE FRAGMENTS; PERTUSSIS TOXIN; POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; URINARY PLASMINOGEN ACTIVATOR; VIRULENCE FACTORS, BORDETELLA;

EID: 0031463337     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.24.7279     Document Type: Article

References (40)

1. Appella, E., Robinson, E.A., Ullrich, S.J., Stoppelli, M.P., Corti, A., Cassani, G. and Blasi, F. (1987) The receptor-binding sequence of urokinase. J. Biol. Chem., 262, 4437-4440.
2. Baggiolini, M., Dewald, B. and Moser, B. (1994) Interleukin-8 and related chemotactic chemokines - CXC and CC chemokines. Adv. Immunol., 55, 97-179.
3. Behrendt, N., Ploug, M., Patthy, L., Houen, G., Blasi, F. and Danø, K. (1991) The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. J. Biol. Chem., 266, 7842-7847.
4. Bianchi, E., Cohen, R.L., Thor, A.T., Todd, R.F., III, Mizukami, I.F., Lawrence, D.A., Ljiung, B.M., Shuman, M.A. and Smith, H.S. (1994) The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res., 54, 861-866.
5. Bianchi, E., Ferrero, E., Fazioli, F., Mangili, F., Wang, J., Bender, J.R., Blasi, F. and Pardi, R. (1996) Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes. J. Clin. Invest., 98, 1133-1141.
6. Blasi, F. (1988) Surface receptors for urokinase plasminogen activators. Fibrinolysis, 2, 73-84.
7. Blasi, F. (1997) uPAR-uPA-PAI-1: a key intersection in proteolysis, adhesion and chemotaxis. Immunol. Today, 18, 415-417.
8. Bohuslav, J., Horejsi, V., Hansmann, C., Stöckl, J., Weidle, U.H., Majdic, O., Bartke, I., Knapp, W. and Stockinger, H. (1995) Urokinase plasminogen activator receptor, beta-2 integrins, and Src-kinases within a single receptor complex of human monocytes. J. Exp. Med., 181, 1381-1390.
9. Busso, N., Masur, S.K., Lazega, D., Waxman, S. and Ossowski, L. (1994) Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J. Cell. Biol., 126, 259-270.
10. Danø, K., Behrendt, N., Brünner, N., Elis, V., Ploug, M. and Pyke, C. (1994) The urokinase receptor: protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis, 8, Suppl. 1, 189-203.
11. Dewerchin, M., Van Nuffelen, A., Wallays, G., Bouché, A., Moons, L., Carmeliet, P., Mulligan, R.C. and Collen, D. (1996) Generation and characterization of urokinase receptor-deficient mice. J. Clin. Invest., 97, 870-878.
12. Estreicher, A., Wohlwend, A., Belin, D., Schleuning, W.D. and Vassalli, J.D. (1989) Characterization of the cellular binding site for the urokinase type plasminogen activator. J. Biol. Chem., 264, 1180-1189.
13. Fibbi, G., Ziche, M., Morbidelli, L., Magnelli, L. and Del Rosso, M. (1988) Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. Exp. Cell Res., 179, 385-395.
14. Grøndahl-Hansen, J. et al. (1995) Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer. Clin. Cancer Res., 1, 1079-1087.
15. Gudewicz, P.W. and Bilboa, N. (1987) Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils. Biochem. Biophys. Res. Commun., 147, 1176-1181.
16. Gyetko, M.R., Chen, G.-H., McDonald, R.A., Goodman, R., Huffnagle, G.B., Wilkinson, C.C., Fuller, J.A. and Toews, G.B. (1996) Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. J. Clin. Invest., 97, 1818-1826.
17. Gyetko, M.R., Todd, R.F., III, Wilkinson, C.C. and Sitrin, R.G. (1994) The urokinase receptor is required for human monocyte chemotaxis in vitro. J. Clin. Invest., 93, 1380-1387.
18. Høyer-Hansen, G., Rønne, E., Solberg, H., Behrendt, N., Ploug, M., Lund, L.R., Ellis, V. and Danø, K. (1992) Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. J. Biol. Chem., 267, 18224-18229.
19. Høyer-Hansen, G., Ploug, M., Behrendt, N., Rønne, E. and Danø, K. (1997) Cell surface acceleration of urokinase-catalyzed receptor cleavage. Eur. J. Biochem., 243, 21-26.
20. Kindzclskii, A.L., Laska, Z.O., Todd, R.F., III and Petty, H.R. (1996) Urokinase-type plasminogen activator reversibly dissociates from complement receptor type 3 (aMb2,CD11b/CD18) during neutrophil polarization. J. Immunol., 157, 297-309.
21. Masucci, M.T., Pedersen, N. and Blasi, F. (1991) A ligand-binding soluble mutant form of the human urokinase plasminogen activator receptor. J. Biol. Chem., 266, 8655-8658.
22. Min, H.Y., Doyle, L.V., Vitt, C.R., Zandonella, C.L., Stratton-Thomas, J.R., Shuman, M.A. and Rosenberg, S. (1996) Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. Cancer Res., 56, 2428-2433.
23. Neer, E.J. (1995) Heterotrimeric G proteins: organizers of transmembrane signals. Cell, 80, 249-257.
24. Nykjær, A., Møller, A.B., Todd, R.F., III, Christensen, T., Andreasen, P.A., Gliemann, J. and Petersen, C.M. (1994) Urokinase receptor. An activation antigen in human T lymphocytes. J. Immunol., 152, 505-516.
25. Pallisgaard, N., Pedersen, F.S., Birkelund, S. and Jorgensen, P. (1994) A common multiple cloning site in a set of vectors for expression of eukaryotic genes in mammalian, insect and bacterial cells. Gene, 138, 115-118.
26. Picone, R., Kajtaniak, E.L., Nielsen, L.S., Behrendt, N., Mastronicola, M.R., Cubellis, M.V., Stoppelli, M.P., Danø, K. and Blasi, F. (1989) Phorbol ester regulates synthesis and affinity of urokinase receptors in monocyte-like U937 cells. J. Cell Biol., 108, 693-702.
27. Pizza, M.G. et al. (1989) Mutants of pertussis toxin suitable for vaccine development. Science, 246, 497-500.
28. Ploug, M. and Ellis, V. (1994) Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom α-neurotoxins. FEBS Lett., 349, 163-168.
29. Ploug, M., Rønne, E., Behrendt, N., Jensen, A.L., Blasi, F. and Danø, K. (1991) Cellular receptor for urokinase plasminogen activator: carboxy-terminal processing and membrane anchoring by glycosylphosphatidylinositol. J. Biol. Chem., 266, 1926-1933.
30. Ploug, M., Rønne, E. and Danø, K. (1993) Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptor. Biochemistry, 33, 8991-8997.
31. Pyke, C., Kristensen, P., Ralfkjær, E., Grøndahl-Hansen, J., Eriksen, J., Blasi, F. and Danø, K. (1991) Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinoma. Am. J. Pathol., 138, 1059-1067.
32. Pyke, C., Græm, N., Ralfkjær, E., Rønne, E., Høyer-Hansen, G., Brünner, N. and Danø, K. (1993) Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res., 53, 1911-1915.
33. Resnati, M., Guttinger, M., Valcamonica, S., Sidenius, N., Blasi, F. and Fazioli, F. (1996) Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J., 15, 1572-1582.
34. Roldan, A.L., Cubellis, M.V., Masucci, M.T., Behrendt, N., Lund, L.R., Danø, K., Appella, E., and Blasi, F. (1990) Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell-surface plasmin-directed proteolysis. EMBO J., 9, 467-470.
35. Shapiro, R.L., Duquette, J.G., Roses, D.F., Nunes, I., Harris, M.N., Kamino, H., Wilson, E.L. and Rifkin, D.B. (1996) Induction of primary cutaneous melanocytic neoplasms in urokinase-type plasminogen activator (uPA)-deficient and wild type mice: cellular bleu nevi invade but do not progress to malignant melanoma in uPA-deficient animals. Cancer Res., 56, 3597-3604.
36. Sølberg, H., Rømer, J., Brünner, N., Holm, A., Sidenius, N., Danø, K. and Høyer-Hansen, G. (1994) A cleaved form of the receptor for urokinase-type plasminogen activator in invasive transplanted human and murine tumors. Int. J. Cancer, 58, 877-881.
37. Stoppelli, M.P., Corti, A., Soffientini, A., Cassani, G., Blasi, F. and Associan, R.K. (1985) Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc. Natl Acad. Sci. USA, 82, 4939-4943.
38. Stoppelli, M.P., Tacchetti, C., Cubellis, M.V., Corti, A., Hearing, V.J., Cassani, G., Appella, E. and Blasi, F. (1986) Autocrine saturation of pro-urokinase receptors on human A431 cells. Cell, 45, 675-684.
39. Ulevitch, R.J. and Tobias, P.S. (1995) Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol., 13, 437-457.
40. Wei, Y., Lukashev, M., Simon, D.I., Bodary, S.C., Rosenberg, S., Doyle, M.V. and Chapman, H.A. (1996) Regulation of integrin function by the urokinase receptor. Science, 273, 1551-1555.